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Childhood cancer after prenatal exposure to diagnostic X-ray
examinations in Britain
R.H. Mole
Heath Barrows, Bayworth Lane, Boar's Hill, Oxford OX] 5DF, UK.
Summary Detailed data were provided by the Oxford Survey of Childhood Cancer OSCC on deaths from
childhood cancer in Britain after irradiation of the fetus during diagnostic radiology of the mother. In each
age group at death, 0-5, 6-9 and 10- 15 years, excess cancer deaths decreased suddenly for births in and after
1958. A major factor was concerted action initiated in 1956 to reduce radiation exposure of fetal gonads for
fear of genetic hazards. Dose reduction was achieved during 1957 and early 1958 by reducing the rising rate of
obstetric radiography and by virtually abandoning pelvimetry as that had been understood. In the 1970s the
rate of X-raying increased again and so did cancer risk but not significantly.
Direct evidence that diagnostic X-rays can cause childhood cancer is the similar excess rate per X-ray in
twins and singleton births when X-raying rate is 5-6 times higher in twins. In the past a dose-response for
cancer in OSCC data based on number of films per X-ray examination was taken to be evidence for causation
but dose per film varies with kind of X-ray examination. Fixed values for dose per film were mistakenly
assumed by UNSCEAR (1972) and used by it and others when deriving risk co-efficients. In updated OSCC
data cancer risk is independent of film number.
The odds ratio for childhood cancer deaths after X-raying in birth years 1958-61 (1.23 with 95% confidence
intervals CI 1.04-1.48) and the mean fetal whole body dose from obstetric radiography in 1958 (0.6cGy) can
each be derived from nationwide surveys in Britain. The corresponding risk coefficient for irradiation in the
third trimester for childhood cancer deaths at ages 0-15 years = 4-5 x 10-4 per cGy fetal whole body dose
(95% CI 0.8-9.5 x 10-4 per cGy). It is the same for cancer incidence and mortality.
A lower risk in bomb survivors exposed in utero is not incompatible since its CI are wide. There is no
dependable evidence that radiosensitivity is greater in early pregnancy. A significantly raised cancer rate after
diagnostic X-raying supports the hypothesis that carcinogenesis by ionising radiation has no threshold.
The aim of this paper is to examine the changes in diagnostic
radiography in pregnancy during the years 1940-79 and to
see how these may be linked with the corresponding changes
in excess childhood cancer rate after intrauterine irradiation
of the fetus.
The first publications alerting clinicians to the possitility
that diagnostic radiography of the abdomen of a pregnant
woman could induce cancer in her child were from the
Oxford Survey of Childhood Cancer OSCC (Stewart et al.,
1956, 1958). How soon after these publication dates was
there a measurable change in clinical practice (Mole, 1989)?
Radiology seemed to change almost at once - mean film
number per X-ray examination was reduced abruptly - but
the decrease in rate of requests for X-rays by obstetricians
lasted only for 10-12 years, then increasing so that in the
1970s it was no smaller than in 1954-7 (cf. Gilman et al.,
1989b). These findings, derived from recently updated data of
the continuing OSCC survey (Knox et al., 1987), could only
be tentative because all data were pooled over ages 0-15
years. The separate observations for ages 0-5, 6-9 and
10- 15 years have now been kindly provided to me by OSCC
authors (Knox et al., personal communication, 1989) and this
report records a more detailed judgment. The data refer to
some 14,500 matched cancer case/control pairs, currently the
largest case/control cancer study ever made. The OSCC 'had
stumbled across the connection between obstetric X-rays and
childhood cancers while looking for something else' (Stewart,
1971).
Technical aspects of obstetric radiology also began to
change in 1956. 'In the light of current pronouncements on
genetic hazards it is likely that X-ray examination of the
pregnant subject will be drastically restricted in the near
future' (Clark, 1956). Concern about hereditary damage
(genetic hazards) was the reason for setting up the Adrian
Committee in 1957 'to review the present practice in diagnos-
tic radiology in the UK'. The work sponsored by the Com-
mittee led to nationwide surveys of the actual practice of
obstetric radiology and to direct measurements in the course
of routine radiography from which radiation dose to the
fetus could be inferred. Neither OSCC publication on
prenatal X-rays and cancer in childhood (Stewart et al., 1956,
1958) was listed as a reference in the Adrian Committee
Reports (Ministry of Health, 1960, 1966).
If diagnostic radiography of the pregnant woman is truly a
cause of childhood cancer, then a quantitative assessment of
risk per unit of radiation exposure is highly desirable. The
numerator, the amount of induced cancer, is provided by
epidemiological studies. The denominator, the radiation dose
within the uterus, is no less important. Britain is the only
country for which numerical values of numerator and
denominator based on nationwide studies can be provided
for the same calendar years of study. Fortuitously, these were
also the last years before mortality began to decrease follow-
ing improved treatment of childhood cancer. The practice of
obstetric radiography was changing so rapidly in Britain in
1956-8 that a detailed review is needed to establish
reasonably valid values both for numerator and denominator
of a risk co-efficient. The circumstances were peculiar to
Britain. North American studies in the field are referred to
only briefly.
The basis of the concern leading to the work of the Adrian
Committee is briefly outlined. Observations on childhood
cancer and diagnostic radiography are considered in turn and
then the particular aspects of obstetric radiography that
determine radiation dose in the fetus. The tables (with one
exception) give detailed information not available elsewhere
in the scientific literature.
Concern over hereditary damage following obstetric radio-
graphy
In the 1950s Muller, the geneticist and Nobel laureate, sug-
gested that a relatively small increase in mutation in the
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human race could lead to its extinction by 'genetic death'.
Genetic death is the specific loss from a population of the
genes of all individuals who leave no descendants, those
whose genes are thus lost for ever (Muller, 1954). Induced
mutation was said to increase genetic deaths. It was accepted
without reservation that mutations were increased linearly in
proporitoh to radiation dose and that there was no dose
threshold below which mutation did not occur. Radiation
was knoyvn to cause leukaemia and cancer after doses large
enough to produce evident tissue damage, as after
radiotherapy or in gross occupational over-exposure in
radiologists and others. It was commonly accepted that the
dose for carcinogenesis had to exceed a threshold. This was
open to question only if carcinogenesis was regarded as
analogous to genetic mutation, not a well-accepted view at
the time. Also, somatic injury in irradiated populations was
then commonly regarded as of secondary importance relative
to hereditary damage, explicitly (by Muller, 1954) or imp-
licitly (Medical Research Council, 1956), an assessment aban-
doned not long afterwards. The Adrian Committee's main
concern was to minimise hereditary damage to the popula-
tion by irradiation of the gonads, although it also had in
mind possible effects from irradiation of the bone marrow
(Spiers, 1957).
Authoritative national reviews of ionising radiation and its
potential to harm populations first appeared in 1956. A few
months later a well-known radiologist wrote 'immediate
attention must be given to reduction of X-radiation dosage
to patients, under the age of 30 years, from X-ray diagnostic
examinations'. One important step can be taken immediately:
'forbid absolutely in all X-ray departments the taking of
Thoms' brim view of the pelvis during pregnancy [original
emphasis]. The fetal gonads are liable to receive from this
'view " alone, about four to five times the total dose received
from all other routine views added together' (Blair Hartley,
1956). 'For more than twenty years I have maintained that
the Thoms' view is both dangerous and unnecessary. I am
given to understand that Professor Thoms himself no longer
advocates it' (loc. cit.). One week later a senior obstetrician
concurred, saying that 'in 1946 and on many subsequent
occas?ons I have pointed out that the method is unnecessary
and probably harmful to the fetus' (Moir, 1956).
Preparatory work had suggested that population fetal
gonad dose in Great Britain from pelvimetry was 2.4 times
that from obstetric abdomen X-rays and that fetal dose per
examination by pelvimetry was six times that for an obstetric
abdomen X-ray (Osborn & Smith, 1956). Thus, when the
Adrian Committee was set up (and Professor Blair Hartley
was co-opted to its Panel on Obstetrics), the practice of
pelvimetry was going to be closely examined. It was only to
be expected that the frequency of pelvimetry would decrease
during the planning stages of the Adrian Committee's work
and before any dose determinations were made.
Past emphasis on hereditary damage caused by fetal gonad
exposure may well have been misplaced. None of the inves-
tigations in Japan has shown a confirmed radiation-induced
increase in mutation in children of bomb survivors (San-
karanarayanan, 1988). There is no scientific doubt that
genetic mutation did occur but it has not been measurable.
Malformations have also not been measurably increased after
in utero irradiation in the human (Mole, 1987b). Cancer
induction is a main radiation hazard.
The Oxford Survey of Childhood Cancer OSCC
The design and conduct of the OSCC have often been des-
cribed (Stewart et al., 1956, 1958; Bithell & Stewart, 1975;
Knox et al., 1987). Each child known to have died with
cancer in England, Wales and Scotland is linked with another
living child of the same sex, the matched control, born in the
same civil administrative district in which the death occurred
and with a closely similar birth date. Using a standard
questionnaire the same person interviews both mothers (but
not all mothers are willing or can be traced). A mother's
memory of being X-rayed during the relevant pregnancy is
checked as far as possible by reference to clinical records (by
family doctors, antenatal clinics and hospitals). A mother's
report that she had been X-rayed was positively confirmed in
some 64% and positively denied in 5% of both cases and
controls (Knox et al., 1987). Failures to confirm were often
because case notes or X-ray records were missing (loc. cit.).
Published tables (Knox et al., 1987) were based on total
claims from both sources, memories of mothers and clinical
records.
The recorded X-rayings are diagnostic examinations
involving abdominal and/or pelvic exposure of women who
were pregnant at the time as confirmed by the time interval
between date of X-ray and date of delivery (Gilman et al.,
1988). Cancer cases were identified through central registers
of deaths but were otherwise undefined by Knox et al.,
(1987). The categories of lethal tumours were listed earlier by
Bithell and Stewart (1975).
When a woman had several X-ray examinations during the
same pregnancy, the details of the first X-ray investigation
were used when analysing the dose response and the timing
of X-raying (Bithell & Stewart, 1975). No corresponding
statement about multiple exposures of a single individual has
been found in subsequent reports.
A death of a child with cancer was the starting point for
enquiries by the OSCC: the year of birth of the child and its
matched control could be anything up to 16 years earlier.
The newest information about X-raying in pregnancy (Gil-
man et al., 1989b) cannot yet be linked with deaths occurring
many years later. The earliest complete cohort was for birth
year 1953 and, in data currently available, the latest complete
cohort is for birth year 1962, ten complete single birth-year
cohorts in all. When deaths at ages 0-5, 6-9 and 10-15
years are examined separately 20, 22, and 20 potentially
complete single-year cohorts are defined by year of birth,
starting and ending in different years according to age at
death.
Observations on childhood cancer
Tables I, II and III give the distribution of cancer
case-control pairs by year of birth and year of death. The
numbers of case-control pairs grouped by birth year and the
per cent X-raying rates for cases and controls are in Tables
IV, V and VI from which numbers of X-rayed cases and of
controls in each cell of these tables can be deduced without
error. Tables I, II and III also include by year of death the
number of children routinely certified as dying because of a
neoplasm in Britain (England, Wales and Scotland) (Draper
& Stiller, personal communication, 1989). Tables IV, V and
VI also give mean number of films per X-ray examination.
This was known, however, only for some, not all, of the
cases and controls.
Table 6 in Knox et al. (1987) gave numbers of radiation-
discordant case-control pairs by year of birth and age at
death. With changes (Knox et al., personal communication,
1989), it is reproduced here as Table VII. The data for cancer
cases in Tables I-VII refer to singleton births only.
This information allows calculation of odds ratios OR
(with confidence intervals) for radiation-discordant cancer
case/control pairs, of X-raying rates, and of mean film
number per X-ray examination for any grouping of years of
birth compatible with the data as provided. Results for ages
at death 0-5, 6-9 and 10-15 years are given in Tables VIII,
IX and X respectively. For my purposes years of birth were
pooled for 1940-7 (the Second World War years and the
immediate post-war years before the National Health Service
was in place, July 1948), for the 6-year period 1948 -53, and
for subsequent four-year periods 1954-7, 1958-61, 1962-5,
1966-9, 1970-3. In each age group the most recent pool of
birth years was only 2 or 3 years long and did not coincide
exactly with the corresponding data on X-raying. Data on
X-raying up to 1981 are given by Gilman et al. (1989b).
Exact 90% confidence intervals for OR in a matched
case-control study were calculated (Morris & Gardner,154 R.H. MOLE
Table I Temporal distribution of years of birth and years of death (matched pairs only), ages 0-5 years I I months
Year ofdeath
Year of
birth 1953 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78
46
47 25
48 66 26
49 71 61 25
50 59 72 51 26
51 71 62 81 50 21
52 52 58 79 65 39 28
53 30 49 80 59 68 56 23
54 21 51 68 65 58 57 18
55 21 41 43 75 64 63 21
56 25 49 58 73 62 55 22
57 24 42 57 64 58 55 22
58 27 54 70 88 58 73 22
59 23 55 73 78 69 69 24
60 19 49 79 68 60 62 26
61 21 55 57 59 79 70 21
62 24 56 55 58 61 62 25
63 33 52 56 78 71 70 21
64 29 48 62 54 67 54 24
65 19 49 68 57 45 35 19
66 29 56 63 58 53 41 14
67 35 38 53 51 44 42 18
68 17 38 35 39 38 35 19
69 17 30 38 52 35 43 10
70 25 33 45 34 36 30 19
71 20 37 29 30 39 33 4
72 19 20 33 24 27 33 15
73 19 26 22 23 19 33
74 11 19 25 21 22
75 21 17 19 17
76 13 18 20
77 - 8 20
78 6
A 374 349 388 334 309 344 351 351 365 371 378 346 346 375 367 337 286 253 234 247 190 198 165 157 122 133
B 441 420 445 440 397 456 481 485 512 516 528 498 503 511 498 533 496 438 396 441 392 322 293 267 269 256
Datafordeathsatages0 -5 years (Knoxetal., personal communication, 1989). Indeathyears 1969 and 1970 thenumberofmatched pairs forbirth
years 1968 and 1969 respectively is larger than in Table 4 in Knox et al. (1987). A = sum ofentries in table (Knox et al., personal communication,
1989). B = number of routinely certified deaths from neoplasm in childhood (G.J. Draper & C.A. Stiller, personal communication, 1989).
1988) using tables of 90%- confidence intervals for the
binomial distribution provided by D.H. Papworth (personal
communication 1989). The same procedure was used for all
OR however small or large the number of radiation-
discordant case-control pairs.
Grouping of cohort birth years The first publications by
Stewart et al. were in September 1956 and June 1958. It
seemed likely a priori that an influence of a 1956 publication
on national data would not be detectable before the end of
1957 (Mole, 1989). So 6-year periods before and after 1957/8
were examined when trying to find the first measurable res-
ponse to these publications (Mole, 1989). The same division
is made here but the observations before and after 1957/8
have been grouped in 4-year periods except for the 6 years
following the setting up of the National Health Service
(1948-53). Birth years earlier than 1948 are considered
separately.
Reliability of a mother's memory for past events. A major
criticism of OSCC observations has been that a mother's
memory is not necessarily reliable. Checks have been made
(Hewitt et al., 1966; Knox et al., 1987) but have not been
reported according to the time interval between the relevant
pregnancy and the date of interviewing the mother. This will
be longest for cancer cases dying aged 10-15 years and their
matched controls, shortest for cancer deaths aged 0-5 years
and their controls. The OSCC data in each grouping of age
at death are examined separately (before pooling) to see if
there are age-dependent differences possibly attributable to
loss of memory with the passage of time.
Completeness of data collection. When follow-up was com-
plete the number of case-control pairs was similar for each
calendar year for deaths aged both 0-5 and 6-9 years. For
the most recent birth years follow-ups are shorter and birth
cohorts become increasingly incomplete (Tables I and II).
The data suggest that the OSCC included a high proportion
of all childhood cancer deaths in Britain, decreasing during
1953-78 from about 80% to 50%. However, OSCC data are
not directly comparable with national totals because their
bases differ. Age is known, but not birth year, for 7% of
cancer deaths in national records 1953-65. OSCC began to
include data from Scotland some years after its start. No
information is available about selection of cases for study of
OSCC.
Collection of data for cancer deaths aged 10-15 years was
not begun until after the 1958 OSCC publication. Inspection
of Table III suggests partial and possibly selective collection
for birth years 1939-43. Deaths for birth years 1944-5 and
1946-7 number about 40 and 80% of the expected. Nineteen
sixty-one seems to be the first year in which data for deaths
at older ages were as comprehensive as for younger ages
(Table III). For the earliest birth years, 1940-7, the data
may be less reliable than for later years: radiography in
pregnancy was not a first priority in war-time, records may
well be defective, and everyday deficiencies of all kinds con-
tinued during the first two post-war years 1946-7. The group
of 1940-7 birth cohorts is kept separate in what follows.
X-raying rate in cancer cases and controls
X-raying rates over the years 1940-77 in cancer cases and in
controls pooled over all ages at death are shown in Figure 1
and also the separate rates for controls matched to deaths at
ages 0-5, 6-9 and 10-15 (significantly different only in
1962-5). The control X-raying rate increased from the pre-
National Health Service years until 1954-7. Over the nextCHILDHOOD CANCER AND PRENATAL IRRADIATION 155
Table II Temporal distribution of years of birth and years of death (matched pairs only), at ages 6-9 years 11 months
Year ofdeath
Year of
birth 1953 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78
42
43 18
44 27 15
45 30 28 9
46 40 36 41 12
47 35 44 48 32 15
48 29 46 38 38 14
49 29 54 23 42 15
50 27 36 47 33 18
51 24 41 40 43 14
52 26 42 43 37 13
53 27 43 32 30 26
54 33 34 33 40 16
55 32 28 40 34 15
56 24 49 37 33 13
57 23 40 31 32 17
58 26 48 39 34 18
59 38 31 43 32 13
60 25 48 39 28 11
61 16 29 29 27 14
62 18 37 25 27 10
63 17 37 37 26 6
64 32 39 32 20 6
65 12 45 16 17 12
66 25 25 21 30 7
67 17 39 24 17 10
68 20 26 22 20 9
69 17 24 18 17
70 13 25 18
71 15 30
72 7
A 150 152 173 163 136 170 157 180 149 128 178 153 165 140 158 136 124 132 129 138 84 103 109 83 88 81
B 188 179 208 221 186 214 218 229 199 179 232 216 235 197 201 220 205 216 239 250 196 183 210 177 185 189
Data fordeaths at ages 6-9 years (Knox etal., personal communication, 1989). A = sum ofentries in table (Knoxetal., personalcommunication,
1989). B = number of routinely certified deaths from neoplasm in childhood (G.J. Draper & C.A. Stiller, personal communication, 1989).
Table III Temporal distribution of years of birth and years of death (matched pairs only), at ages 10-15 years 11 months
Year ofdeath
Year of
birth 1953 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78
1939 1
40 1 4
41 9 6 2
42 4 12 10
43 1 9 15 12 14
44 1 6 15 21 10 8 1
45 4 9 15 13 9 12 18
46 7 15 10 19 25 45 23
47 12 13 17 17 35 36 14
48 7 20 10 33 40 45 25
49 13 14 43 35 25 24 16
50 12 28 29 48 40 31 15
51 13 33 17 26 30 38 17
52 15 26 23 25 26 35 12
53 14 24 32 34 34 28 20
54 14 31 25 35 32 30 10
55 14 38 31 24 29 24 8
56 16 32 26 28 27 11 8
57 15 32 23 26 25 23 12
58 10 22 23 30 22 21 14
59 12 28 17 15 15 22 7
60 21 34 18 23 17 21 8
61 14 19 23 19 29 18 7
62 11 23 27 21 21 28 12
63 10 23 16 18 12 21
64 8 18 26 16 19
65 9 18 13 21
66 10 21 15
67 15 19
68 8
A 2 1 33 68 87 67 86 91 215 211 189 176 179 192 199 164 164 159 139 116 127 130 121 119 112 115
B 2 2 58 97 112 102 136 126 302 308 278 258 274 258 295 276 290 282 264 259 293 226 241 240 246 244
Datafordeathsatages 10-15years(Knoxetal.,personalcommunication,1989). Ineachdeathyear 1961-4,1967and 1968thenumberofmatched
pairs forbirth years 16 yearsearlierislargerthan in Table4in Knoxetal. (1987). A = sums ofentries in table(Knox etal., personalcommunication,
1989). B = number of routinely certified deaths from neoplasms in childhood (G.J. Draper & C.A. Stiller, personal communication, 1989).156 R.H. MOLE
Table IV Proportions of X-rayed cases and controls by year of
birth, ages 0-5 years 11 months
Case- X-rayed children Mean films per
control Cases Control examination
Birth year pairs % % Cases Controls
1940-41 - - -
1942-43
1944-45 - - - -
1946-47 25 8.0 4.0 3.0 -
1948-49 249 12.4 7.2 2.3 2.0
1950-51 493 17.0 9.9 2.6 2.4
1952-53 686 16.0 11.8 2.5 2.3
1954-55 666 19.4 10.7 2.3 2.2
1956-57 666 18.8 13.8 2.1 2.0
1958-59 783 11.6 9.3 1.8 1.7
1960-61 725 12.4 9.7 1.7 1.5
1962-63 722 13.3 10.4 1.6 1.3
1964-65 630 14.6 12.9 1.6 1.3
1966-67 595 13.4 11.3 1.3 1.4
1968-69 446 14.8 12.8 1.5 1.5
1970-71 414 20.5 14.3 1.2 1.3
1972-73 313 21.4 17.3 1.3 1.4
1974-75 172 22.1 16.3 1.1 1.5
1976-77 79 15.2 8.9 1.2 1.3
1978 6 16.7 50.0 2.0 1.7
Total 7670 15.6 11.7 1.9 1.7
Data for cancer deaths at 0-5 years and their matched controls
(Knox et al., personal communication, 1989).
Table V Proportions of X-rayed cases and controls by year of
birth, ages 6-9 years 11 months
Case- X-rayed children Mean films per
control Cases Control examination
Birth year pairs % % Cases Controls
1940-41 - - - -
1942-43 18 5.5 11.1 - 1.0
1944-45 109 10.1 8.3 2.2 1.4
1946-47 303 13.5 2.3 3.4 2.0
1948-49 328 15.2 7.3 2.5 1.9
1950-51 323 17.3 8.0 3.0 2.4
1952-53 319 15.4 13.2 2.3 2.5
1954-55 305 20.0 16.4 2.5 2.2
1956-57 299 25.4 13.0 1.9 1.7
1958-59 322 14.9 11.8 1.6 1.5
1960-61 266 11.7 9.0 1.9 1.1
1962-63 240 11.7 17.1 1.1 1.5
1964-65 231 13.9 13.4 1.3 1.3
1966-67 215 10.7 13.9 1.2 1.5
1968-69 173 16.8 8.7 1.3 1.6
1970-71 101 15.8 19.8 1.2 1.4
1972-73 7 14.3 0.0 - -
1974-75 - - -
1976-77
1978 - - - - -
Total 3559 15.5 11.2 2.1 1.8
Data for cancer deaths at 6-9 years and their matched controls
(Knox et al., personal communication, 1989).
decade it stayed the same and in the 1970s increased slightly.
A similarly timed but more extreme cycle ofchange in rate of
abdominal X-raying of pregnant women was seen in a major
maternity centre, increasing to 40% in 1955 and decreasing
to 11% in 1961. In 1974, at 23%, it was almost double the
1961 rate (Table III, Carmichael & Berry, 1976). In birth
years 1970-81 the mean national X-raying rate decreased
slightly from about 15% to 12% (OSCC data, Gilman et al.,
1989b).
During 1943-57 X-raying rate in cancer cases increased as
in controls but was always at a higher level. In 1958-61 it
decreased abruptly nearly to control rates but by the 1970s
had climbed to values as high as in 1954-7 (Figure 1). The
abrupt decrease in case/control difference in 1957/8 might
suggest an immediate reaction to the publications by Stewart
et al. (1956, 1958) but, as will be seen, other factors are
involved. The difference in X-raying rate between cases and
Table VI Proportions of X-rayed cases and controls by year of
birth, ages 10-15 years 11 months
Birth year
1940-41
1942-43
1944-45
1946-47
1948-49
1950-51
1952-53
1954-55
1956-57
1958-59
1960-61
1962-63
1964-65
1966-67
1968-69
1970-71
1972-73
1974-75
1976-77
1978
Total
Case-
control
pairs
22
77
142
288
350
377
348
345
304
258
271
243
148
80
8
X-rayed c
Cases
4.5
10.4
6.3
9.7
11.4
10.9
18.7
20.0
14.5
12.8
11.4
9.9
15.5
13.7
0.0
.hildren Mean films per
Control examination
% Cases Controls
18.2 - 1.0
3.9 2.0 1.0
7.0 1.0 1.0
4.5 2.5 2.7
6.3 1.6 1.8
11.1 1.6 1.8
13.8 1.8 2.1
12.5 1.8 1.9
13.1 1.8 2.2
12.8 1.5 1.0
11.1 1.4 1.1
10.7 1.5 1.6
8.1 1.0 1.0
11.3 1.0 1.5
12.5 - 1.0
_ _ 1.0
3261 13.1 10.3 1.7 1.7
Data for cancer deaths at 10-15 years and their matched controls
(Knox et al., personal communication, 1989).
controls (Tables VIII, IX and X) was in the direction
expected if diagnostic X-rays are carcinogenic (except in
1962-5 and 1970-1 for cancer deaths at ages 6-9).
Number ofX-rayfilms per X-ray examination
The number of films per X-ray examination was used as a
surrogate for magnitude of radiation dose when claiming that
cancer rate increased progressively with increase in X-ray
exposure (Stewart & Kneale, 1970a; Bithell & Stewart, 1975).
It was based on a hospital's record and, when this did not
exist, on an estimate by the hospital of the likely number of
films that would have been exposed (Bithell & Stewart, 1975).
Records and estimates were in the ratio 7:3 for both cancers
and controls (Table 1, Kneale & Stewart, 1976a). Thus
assessment of film number depended partly on an
uncheckable recall of past events though not at all on a
mother's memory. Kneale and Stewart (1976b) said the high
proportion of pre-1960 deaths without a confirmed record
'was due partly to the absence of systematic recording of
X-ray findings until completion of the pilot study of 1953-55
deaths [Stewart et al., 1958] and partly to the inefficient
recording of results of routine pelvimetries'.
Mean number of films per X-ray examination averaged
2.1-2.2 for 1948-57 and 1.3-1.4 subsequently (Table XIA).
A similar decrease is seen in the late 1950s when birth years
are grouped differently (Table XIB and C). Differences
between cancer cases and their controls were small except for
the earliest birth years 1940-7 (Table XIA). But these data
can be no more than indicative since, as noted, film number
per X-ray examination depended partly on an uncheckable
recall of past events.
The case/control ratio of film number per X-ray examina-
tion is compared with the case/control ratio of X-raying rate
in Figure 2 (the three age-at-death groups pooled). The
former ratio was close to unity after 1940-7 (unexpectedly
less than 1 after 1965). Film number seems less important for
carcinogenesis than X-raying rate.
Reasonsfor X-raying
In controls and cancer cases 14% and 17% of all obstetric
X-ray examinations in birth years 1945-78 were pelvimetries
(Gilman et al., 1988). Pelvimetry was not mentioned
specifically in a detailed cross-correlation of reasons for X-
raying and the related findings (Kneale & Stewart, 1976b).CHILDHOOD CANCER AND PRENATAL IRRADIATION 157
Table VII Radiation-discordant case/control pairs distributed by year of birth and age at death (showing number of pairs in which only the
case (a) or only the control (b) was X-rayed)
Age at death (years)
0,1 2,3 4,5 6,7 8,9 10,11 12,13 14,15 Total
Year of birth a/b a/b a/b a/b a/b a/b a/b a/b a/b
1940-3 -/- -/- -/- -/- -/2 2/- 4/3 2/1 8/6
1944-5 -/- -/- -/- -/3 5/3 2/1 3/2 4/5 14/14
1946-7 -/- -/- 1/- 8/1 12/2 7/1 5/2 11/9 44/15
1948-9 -/- 2/- 14/7 16/4 17/11 8/2 16/8 11/6 84/38
1950-1 3/- 17/16 22/9 23/12 19/5 11/10 11/12 10/13 116/77
1952-3 10/7 30/20 26/15 25/19 16/16 18/7 17/13 23/21 165/118
1954-5 17/17 41/22 41/19 28/20 23/19 20/10 17/14 20/7 207/128
1956-7 25/19 42/15 21/24 43/15 19/10 18/12 6/15 14/6 188/116
1958-9 24/14 35/27 20/21 26/20 18/12 12/10 5/9 11/9 151/122
1960-1 26/15 23/27 27/18 10/9 18/12 13/11 11/7 4/9 132/108
1962-3 24/16 29/28 29/16 14/21 8/14 8/5 7/10 4/4 123/114
1964-5 20/19 33/31 24/15 17/18 9/7 8/4 6/2 -/- 117/96
1966-7 27/26 24/15 17/15 12/13 7/13 4/4 -/- -/- 91/86
1968-9 16/9 17/25 20/11 16/4 8/5 -/- -/- -/- 77/54
1970-1 27/15 21/17 21/11 8/8 -/- -/- -/- -/- 77/51
1972-3 21/17 13/9 11/6 -/- -/- / l - 45/32
1974-6 25/13 4/5 -/- -/- -/- -/- -/- -/- 29/18
Total 265/187 331/257 294/187 246/167 179/131 131/77 108/97 114/90 1668/1193
Data from Table 6 in Knox et al. (1987) with four additional discordant pairs; one control b for 1940-3 birth years, 14,15 years at death;
one control b for 1944-5 birth years, 10,11 years at death; one control b for 1946-7 birth years, 6,7 years at death; and one case a for 1972-3
birth years, 2,3 years at death (Knox et al., personal communication, 1989).
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Figure 1 Rate of X-raying in utero of future cancer cases and
future matched controls in OSCC according to birth years
1940-1977, grouped as in Tables VIII, IX and X, and of other
surveys in UK of the surviving children of women X-rayed when
pregnant. The continuous line connects the grouped cohort-
specific mean values for X-raying of cancer cases at all ages at
death. The dashed line connects the grouped cohort-specific mean
values for X-raying of controls matched for all ages at death.
Individual mean values for controls matched to cancer cases
dying at 0-5 years old A, at 6-9 years old 0, and at 10-15
years old X. For birth years 1962-5 the X-raying rate of controls
matched to cancer deaths at ages 6-9 years was 15% and at ages
0-5 years and 10-15 years was 12% and 10% respectively, the
only statistically established difference in X-raying rate within any
grouped birth cohort of controls. The rates for all ages are
virtually the same as in Gilman et al. (1989b) except for cases in
the 1970s where numbers of observations were larger and rates
slightly smaller than in this figure. X-raying rate in pregnancy in
other UK surveys: National Birthday Trust in 1958 (Stewart,
1973) and in 1970 (Dr J. Golding, personal communication,
1989) *; Adrian Committee survey in Dec 1957 (rate from
Kendall et al., 1980) A.
X-raying for twins proved positive in 67% of future cases
and 28% of future controls (620 cases, 473 controls). Only
1-2% of X-raying for other reasons revealed twins.
Stated reasons for X-raying over the 43 birth years
1939-81 were closely similar in future cases and future con-
trols (Gilman et al., 1989b), except for non-obstetric reasons
in the early birth years 1939-49 (11% of all reasons in cases,
2% in controls). X-raying for twins averaged about one in
three of all examinations over the 43 year period. Fetal
maturity, as a reason, increased strikingly from 1-2% in
1939-49 to 8-11% in 1960-9 and then to 25-26% in
1970-81, and absence of a recorded reason decreased from
about 50% to 25%. These data concern reasons for X-rays,
not findings.
Odds ratiofor cancer: radiation-discordant case/controlpairs
The odds ratio (OR) is the number of paired X-rayed cancer
cases with matched but not X-rayed controls divided by the
number of paired cancer cases not X-rayed and with matched
controls who were X-rayed (Table VII). Differences in OR
for different ages at death were small within each birth year
grouping (Table XIII). In each age-at-death group OR was
higher for births before 1958 than for births after 1957,
significantly so for ages 6-9 years and for all ages pooled
(Table XIII). OR for birth years 1958-65 and 1966-9 was
the same. Something occurring about 1957/8 reduced cancer
risk after prenatal exposure to X-rays. When all ages at
death are pooled, OR for the 4 year birth cohorts
1953-7= 1.62 (90% CI 1.40-1.87) and 1958-61 = 1.23
(90% CI 1.05-1.44).
OR values for 1940-7 are the largest but also have the
widest confidence intervals (Table XIII). If data from these
war and immediate post-war years are accepted as valid, then
some reduction in the effect of X-raying may have occurred
long before attention was drawn to the cancer risk by the
first publications of Stewart et al. (1956, 1958). The progres-
sive decrease in relative risk with calendar year of birth in
Figure 2 in Bithell and Stewart (1975) depended largely on
the inclusion of births in 1940-7.
Matching of controls by place of birth as well as place of
death. When cases and controls share a common birth year,
the mean intrauterine radiation dose is likely to have been
similar, independently of systematic changes in fetal dose per
X-ray examination over the years 1940-77. Some 16-21%
of cancer cases moved to a new administrative district
between birth and death (Knox et al., 1987). Thus for
79-84% of case/control pairs the matching of cases and
controls was by place (civil district) of birth, as well as of
death, implying that the circumstances of X-raying before
birth were usually similar, especially since the commonest
time of prenatal X-raying is shortly before birth (Table XIV).
When range of fetal dose and its mean are similar, the ratio
of X-raying rate in cancer cases to that in matched controls
is a simple measure of relative risk for carcinogenesis by
X-rays that is insensitive to temporal changes in specific
magnitude of fetal dose per examination. This ratioIt
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Table XI Number offilms per X-ray examination in cancer cases and in their matched
controls according to calendar years of birth and the age at death of the cancer cases
Age at death
ofcancer cases
Film number per examination in
birth year cohorts
Aa
Cancer cases
0-5 years I I months
6-9 years 11 months
10-15 years 11 months
All ages
Matched controls
0-5 years 11 months
6-9 years 11 months
10-15 years 11 months
All ages
Bc
Cases
Controls
Cd
Controls
all ages
all ages
all ages
1940-7 1948-57 1958-65 1966-9
3.1
2.1
2.6
1.6
1.7
1.7
1943-9
2.5
1.9
2.3
2.4
1.7
2.2
2.2
2.1
2.0
2.1
1950-4
2.4
2.2
1.7
1.5
1.4
1.6
1.4
1.3
1.2
1.4
1955-9
2.0
1.9
1.4
1.3
(1.0)b
1.3
1.5
1.5
(1.5)b
1.5
1960-5
1.6
1.5
1939-49 1950-9 1960-9 1970-81
1.77 2.10 1.39 1.39
aFromTablesVIII, IXandX.bValuesbasedonverysmallnumbers(TableVI).CDerived
from Table I in Stewart & Kneale (1970a). dFor dated X-rayings (Table 3, Gilman et al.,
1989b).
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Figure 2 Cancer case/control ratios for rate ofX-raying and for
film number per X-ray examination according to birth years
1940-1977, grouped as in Tables VIII, IX and X, for all childhood
cancer deaths at ages 0- 15 years and their matched controls.
X-raying per cent case/control *-*; Film number per X-ray
examination case/control 0--0.
Table XII Mantel-Haenszel estimates of relative risk for X-rays
classified by trimester and number of films
X-ray specifications Relative risk'
Exposure date First trimester 2.69
Second trimester 0.91
Third trimester 1.00 X2(3)= 9.05
No record 1.01 0.025<P<0.05
Number of films 1 1.00
2 1.08
3 0.97 X2(5) = 1.83
4 1.07
5+ 1.18
No record 0.94 Not significant
aControllingfactors: sex,birthyear, socialclass,maternalage,sibship
position, also exposure-age or film number (see text). The relative risk
for each test factor level is compared with the factor level setting the
standard (i.e. RR= 1.00). Table 2, Gilman et al. (1988). The
information on intrauterine age atexposure and onfilm numberwas all
obtained from medical records and is not dependent on a mother's
recollection ofevents. It came from 58% ofboth cases and controls but
not exclusively from case/control pairs.
decreased from 1954-7 to 1958-61 in each of Tables VIII,
IX and X.
Other carcinogenic influences inpregnancy
Many possibly causal factors have been isolated by condi-
tional logistic regression applied to case/control pairs in the
OSCC (Gilman et al., 1989a). The dates when specific drugs
were introduced or became commonly used, such as
pethidine for pain relief in labour, or when specific proce-
dures were abandoned, such as vaccination against smallpox,
were not taken into account. The OSCC did not begin to
record the use of drugs in pregnancy until 1964 (Knox et al.,
1987). In this review of data from death years 1953 onwards
I have assumed that paired cases and controls were likely to
be more like each other for other possible causal factors in a
group of 4-6 consecutive birth years than for all birth years
1940-76 pooled.
It was reported (Knox et al., 1987; Gilman et al., 1989a)
that RR for irradiation in the OSCC data increased when the
carcinogenic influence of other factors in pregnancy (mater-
nal illnesses, drugs etc) were allowed for but this was the
result of an error in statistical inference (Muirhead & Kneale,
1989). Nevertheless, in the OSCC birth cohorts for 1964-79
the carcinogenic 'effect of X-rays is certainly not reduced by
controlling for illnesses and drugs' (loc. cit.).
Aspects of obstetric radiography
X-raying rate during pregnancy: surveys other than the OSCC
In England in 1973-4 the abdominal X-raying rates in preg-
nancy were 8.6% and 16.5% in two, and 23-35% in six, of
eight major hospital maternity centres (Carmichael & Berry,
1976). Rates 23-35% are unexpectedly higher than the mean
rate for the 1970s in OSCC matched controls (Figure 1). In
both the rate is for X-raying of mothers (not of fetuses).
(Matched OSCC controls sometimes included one of a pair
of twins but never both). Thus X-raying rate could differ
widely between different localities. The lowest rate, 8.6%,
came from a centre without its own X-ray equipment.
The only reference to X-raying in pregnancy in a national
survey of births in 1946 is a note that pelvic X-ray
measurements were made at the thirty-second week in nearly
all primigravidae in Kent (Joint Committee, 1948). Some
post-war clinics used pelvimetry as a routine in primigra-
vidae (Browne, 1951). The nationwide rate of obstetric
radiography in 1957 was 11.4% in live births (Kendall et al.,
1980).
In 1958 and 1970 a longitudinal study of all births in one
week in Great Britain was organised by the National Birth-
day Trust NBT (Butler & Bonham, 1963; Chamberlain et al.,
1978). Soon after each birth its circumstances were noted
from contemporary records: X-raying in pregnancy was a
o 1 I I I
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Table XIII Odds ratios with 90% confidence intervals for X-raying ofcancer cases vs matched controls
according to calendar years of birth and age at death of the cancer cases
Birth year cohorts
1940-7 1948-57 1958-65 1966-9
Age at death OR 90% CP OR 90% CI OR 90% CI OR 90% CI
0-5 years 11 months 1.64 1.39-1.93 1.27 1.09-1.93 1.20 0.93-1.54
6-9 years 11 months 2.27 1.20-4.50 1.75 1.43-2.13b 1.06 0.83-1.36b 1.23 0.82-1.84
10-15 years 11 months 1.67 1.06-2.65 1.41 1.17-1.70 1.11 0.83-1.49
All ages 1.86 1.40-2.55 1.59 1.44-1.76b,c 1.19 1.06-1.33b,cd 1.21 0.97-1.49d
'OR 90% CI = odds ratio with 90% confidence intervals. "90% confidence intervals for birth years
1948-57 and 1958-65 do not overlap. C95% confidence intervals do not overlap, 1.41-1.80 and 1.05-1.35
respectively. dOR for pooled birth years 1958-69 = 1.19 (90% CI 1.08-1.31).
Table XIV Dated X-rays in pregnancy at different stages ofintra-uterine development:
mothers of future childhood cancers and future matched controls (Table 8.2, Mole,
1989)a'
Number ofabdominal andpelvic X-ray exposures
Obstetric Non-obstetric examinations
Age post-conception examinations Alld Withfluoroscopy
(completed weeks) Cancer Control Cancer Control Cancer Control
Conceptus
and embryo 0-7 3 3 22 5 7 3
Fetal I 8-24 70 48 27 17 8 5
Fetal II 25-38 1299 996 18 18 1 1
aPartition offluoroscopicexaminations betweenconceptus andembryoand fetal stage I
wasincorrect in Table 8.2, Mole(1989). bX-raysconfirmed bymedical records in 1944-78
of 1,439 future cancers and 1,087 future controls (Table 5, Gilman etal., 1988), excluding
four cancers and one control X-rayed more than 38 weeks before delivery (Knox et al.,
personal communication, 1989). Cases and controls were not matched pairs. cAge
post-conception (completed weeks) at time ofX-raying = 38 weeks less interval between
X-ray date and birth date (weeks), 38 completed weeks from oocyte fertilisation to birth
dayis the 'standard' duration ofnormal development in utero. Conceptusandembryo are
within the first trimester. Fetal I corresponds to last month offirst trimester plus second
trimester, fetal II to third trimester. dOnly in 1939-49 were non-obstetric X-rays much
morefrequentinfuturecancercasesthan futurecontrols, 10.5and 1.9%, but4.9and4.1%
in 1950-81 (Table 4, Gilman et al., 1989b). eExaminations using contrast medium (but
excluding pyelography) from Table 3 (Gilman et al., 1988), with additional information
about numbers ofcases and controls in my categories conceptus and embryo and fetal I
(Knox et al., personal communication, 1989).
specific datum to be recorded. 1958 NBT data for survivors
at one month after delivery gave an X-raying rate 10.7% for
singletons and 11.6% for all children, singletons and twins
(Stewart, 1973). The corresponding rates in OSCC controls
(mothers) for singleton births in 1958-9 were 10.6% overall,
and 9.3%, 11.8% and 12.8% for controls matched for cancer
deaths at ages 0-5, 6-9 and 10-15 years (data in Tables IV,
V and VI).
The 1970 NBT cohort of neonatal survivors had an
X-raying rate of abdomen and/or pelvis for all mothers
2045/16357 (Dr J. Golding, personal communication,
1989) = 12.5% (s.e. 0.26%), for mothers of singletons 11.9%
and of twins 73%. The 1970-1 rate in OSCC matched
controls 79/515 (Tables IV, V and VI) = 15.3% (s.e. 1.6%)
and in all OSCC controls 94/629 (Table I, Gilman et al.,
1989b) = 14.9% (s.e. 1.4%). The respective t values for excess
above the 12.5% NBT rate are 1.8 and 1.7 (P=0.05-0.1).
If rates of radiography vary substantially between civil
districts and if X-ray exposure does induce cancer in the
fetus, then the OSCC method for selection of matched cont-
rols will give a control X-raying rate larger than the true
population rate. There must be (on average) a higher child-
hood cancer rate in children born in localities with relatively
high X-raying rates in pregnancy than in localities with
relatively low X-raying rates. Thus controls with the same
place of birth as cancer cases will come more often than
randomly from localities with higher X-raying rates and less
often than randomly from localities with relatively low X-
raying rates. But the data in the previous two paragraphs
show that the method of selection of OSCC controls did not
cause large deviations of OSCC rate from the true X-raying
rate either in 1958 or 1970-1.
The low obstetric X-raying in pregnancy in 1978-9
reported by Kendall et al. (1980) underestimated it by 2-3
times (Kendall et al., 1989). By the late 1970s ultrasound was
commonly used for fetal surveillance but had hardly
influenced the X-raying rate in pregnancy (Gilman et al.,
1989b).
The Adrian Committee survey ofradiologicalpractice 1956-8
When planning to estimate population gonad dose
originating in medical radiology the Adrian Committee
needed to know the number of each type of X-ray examina-
tion carried out per year and the associated specific gonad
dose. Preliminary estimates of numbers and types for 1955
were based on a small sample of hospitals. Later a question-
naire asked all NHS hospitals, clinics etc to record the
number of X-ray examinations of different types in a
specified week in April/May 1957. A second questionnaire
sent to a random 25% sample of NHS hospitals stratified by
size asked for similar but not identical information for a
specified week in December 1957.
In December as compared with May 1957 the reported
X-raying rate was smaller by 30% for obstetric abdomen
examinations and by 50% for pelvimetry (Table XV). 'The
impression was left that by mid-1958, when the [dose]
measurements were made, there had been a further decrease,
although there is no firm evidence in support of this. Several
hospitals reported that they no longer carried out such
examinations while others had reduced their numbers dras-
tically, in some cases to 10% or less of the pre-1956 figure.'CHILDHOOD CANCER AND PRENATAL IRRADIATION 161
Table XV Estimated number of obstetric radiological examinations
per year in England and Wales (from Table 45 and text of Osborn,
1960)
Obstetric abdomen Pelvimetry
Inferred from a sample at least at least
of 10 hospitals 1955 86,000 26,000
Response to
questionnairea May 1957 82,000 26,000
Response to
questionnairea Dec 1957 59,000 14,000
aNumber in a specified week x 52 and adjusted to exclude Scotland.
(p. 104, Osborn, 1960). Even before measurements were made
the contribution of pelvimetry to gonad dose was declining
(Spiers, 1957). Thus reduction in radiography for obstetric
purposes seems adequate to explain the specific shortfall in
dose measurements for obstetric but not other X-ray
examinations. The numbers asked for were based on the May
1957 questionnaire but in 1958 only 32% of requested
measurements for pelvimetry were actually made, as com-
pared with 121% for chest X-rays and 65-90% for other
kinds of examination (Appendix 1 Table 7, Ministry of
Health, 1960).
Dose to the ovary in general medical radiology. The mag-
nitude of ovary dose in an X-ray examination is some indica-
tion of level of intrauterine dose. Ovary dose in diagnostic
X-ray examinations varied widely between different hospitals
and even within single departments of radiology. One or two
hospitals did not restrict the X-ray beam, which could be up
to a measured 1.3 m in diameter (Osborn, 1961). Few X-ray
sets were equipped with a light beam diaphragm allowing the
X-ray beam to be restricted to the useful area of an X-ray
film. Ovary dose ranged from maximum values in the direct
beam to minimum values when the beam area did not exceed
that of the film being exposed and the only radiation
reaching the ovary was from scatter within the body of the
woman. Consequently the range for chest, heart and lung
X-rays was nearly 5 orders of magnitude from 0.01 to
500 mR (Figure SA, Appendix 1, Ministry of Health, 1960)
and dose distribution was highly skewed in each case. (Note
that in this review of effects of diagnostic X-rays the radia-
tion dose is stated in the same units as in the original
publications. For my purposes R, rad and cGy are taken as
interchangeable.)
In women in 1958 the ovary was in the direct beam in over
50% of routine large film X-rays of the chest and in 9% of
X-ray examinations of arm and hand (Osborn, 1963). Mean
ovary dose was 2.2 and 3.6 mR for X-rays of arm, hand and
of leg, foot (Matthews & Miller, 1969), about half the mean
ovary dose 5.4 mR per examination for chest X-rays (Table
1, Appendix 1, Ministry of Health, 1960). The assertion that
X-raying of chest and extremities would have no effect on the
fetus in utero (Kneale & Stewart, 1980), taken literally, seems
not to apply before 1959.
Limiting an X-ray beam to the useful area of a film was
the major Adrian Committee recommendation for reducing
gonad dose in all radiological examinations (Ministry of
Health, 1960). By 1964 mean ovary dose in adult women
receiving a chest X-ray in the Sheffield Region had been
reduced 26-fold from 5.5 to 0.21 mR per examination (Mat-
thews & Miller, 1969). In 1978-9 a nationwide value was
0.2 mrad (Wall et al., 1980), no smaller than 15 years earlier
in the Sheffield region.
Obstetric X-ray examinations and fetal radiation dose An
obstetric abdomen X-ray is intended to image the whole
fetus. A large film is used and the fetus will be more-or-less
uniformly irradiated. In pelvimetry the aim is to show the
bony structure of the maternal pelvis and the part of the
fetus within the pelvis at the time. Details of projection and
technique determine how much of the fetal body and gonads
are in the direct beam and how much is exposed only to
scattered radiation. Occasionally pelvimetry is needed in a
non-pregnant woman who has recently had a difficult labour
and needs advice about future pregnancies.
In 1958 the range of maternal ovary and fetal gonad dose
in obstetric abdomen and pelivimetry examinations was
about two orders of magnitude (Figures 5E and F, Appendix
1, Ministry of Health, 1960), much smaller than the five
orders of magnitude for maternal ovary dose in other diag-
nostic examinations. In obstetric abdomen examinations the
maternal ovary is in the direct beam, scattered radiation is
relatively unimportant, mean dose is much larger and dose
distribution is much less skewed.
Mean fetal gonad dose in different pelvimetric projections
differed by up to 16-fold (Table XVI). Thus fetal dose in
pelvimetry cannot be assessed without specific knowledge of
the projections used. If Thoms' view is omitted (as strongly
recommended by Blair Hartley, 1956) and a four projection
pelvimetry is replaced by a three (or two) projection
examination, the total fetal gonad dose is reduced by 2.5-3
times (or more), from about 3,500 to about 1,300mR (or
less) (Table XVI). Thoms' projection must have been rarely,
if ever, used in 1958 when mean fetal gonad dose for pel-
vimetry was 885mR (Table I, Ministry of Health, 1960).
Mean fetal gonad dose for the same pelvimetry projections
differed 5-fold in two London teaching hospitals (Osborn,
1951; Stanford, 1951). A report from a specialist maternity
hospital in London (Martin & Williams, 1946) indicates that
doses in earlier years could sometimes have been as low as
for good techniques in the late 1950s, confirming that fetal
dose in pelvimetry varied widely during the years before
1958.
Change in practice and meaning of 'pelvimetry' in
1957-8. Pelvimetry was being developed during the decade
before the Adrian survey. Seven techniques were described in
a major British textbook on X-ray diagnosis (Williams,
1950). Each was intended to give information about
mechanical aspects of delivery, the dimensions of the head of
the fetus (its largest part) and of the birth canal within the
maternal pelvis through which the fetal head must pass. In a
standard British textbook on antenatal care Moir wrote
(1951, 1955): 'The practical value of X-ray pelvimetry is now
generally agreed by both obstetricians and radiologists....
Hitherto, radiologists have been feeling their way with these
new methods of investigation, but now, with better techni-
ques, and better methods of interpretation of the radiog-
raphic findings, they can give much firmer guidance to the
obstetrician.' Before the Adrian survey methodology in pel-
vimetry was not standardised and consequently fetal dose
was not standardised either.
Table XVI Mean fetal and maternal gonad dose in pelvimetry
according to projection (Table VII, Ministry of Health 1960)
Mean gonad dose mR per exposure
Projection Maternal ovary Fetal gonad
1. Antero-posterior 460 630
2. Lateral 577 535
3. Sub-pubic arch and pelvic 670 140
outlet
4. Supero-inferior, pelvic inlet or 992 2,242
Thoms'ab
All four projections were described as routine examinations in Clark
(1956). In the next edition Clark (1964) said about pelvimetry in
pregnant women 'only two projections are used', projection no. 4 'can
no longer be tolerated' and no. 3 'is not a routine'. aAlso termed
antero-posterior oblique 'brim view' (e.g. Clayton et al., 1957).
bProjection no. 4 was abandoned as a routine procedure because of
concern over the magnitude of the associated fetal gonad dose, even
when using Moir's method which ensured that the fetal gonads were
usuallyoutsidethedirect X-raybeam. Moir(1960)wrotethat thepelvic
inlet view 'cannot be recommended for the woman near term. Clear
pictures are not possible'. This difficulty is unavoidable when the bulky
gravid uterus is interposed between the X-ray tube focus and the
maternal pelvis (c.f. Figure 6 and 7, Clayton et al., 1957).162 R.H. MOLE
During 1958 a single lateral exposure of the pelvis tended
to be described as a pelvimetric examination (the late Profes-
sor R.E. Ellis, personal communication, 1963). It came to be
accepted that in a great majority ofcases a single lateral view
of the pelvis (projection 2, Table XVI) interpreted by an
experienced radiologist would meet the needs of an obste-
trician concerned with possible disproportion between a
baby's head and the space within the pelvis necessary for safe
delivery (Dr J.H.E. Carmichael, personal communication,
1989). Previously a routine pelvimetry always involved multi-
ple films, at least one for each of two, three or more projec-
tions (Moir 1951, 1955; Williams, 1950; Table XVI). In 110
measured pelvimetric examinations in 1958 (Ministry of
Health, 1960), 69 used only a single film, of which 63 were
lateral projections (Table XVII).
The 1964 edition of a widely used medical radiographer's
bench book said about pelvimetry, 'one or two projections
are used [cf. Table XVI]: the pelvic inlet projection [Thoms']
can no longer be tolerated as a routine . . . the view of the
pelvic outlet is not a routine' (Clark, 1964). The 1956
forecast was fulfilled: 'In the light of current pronouncements
on genetic hazards it is likely that X-ray examination of the
pregnant subject will be drastically restricted in the near
future' (Clark, 1956).
Change in film number per X-ray examination in preg-
nancy. An abrupt decrease in film number per examination
in the late 1950s is confirmed in Adrian survey data. Film
number per examination for pelvimetry was up to nine and
not less than three in seven different hospitals in 1955/6
(Osborn & Smith, 1956). In December 1957 mean number
was 2.0 for pelvimetries and 1.3 for obstetric abdomen
examinations (Table 4, Appendix 1, Ministry of Health,
1960). At the measured examinations some months later in
1958, mean film number was 1.7 (or 1.53, Table XVII) for
pelvimetry and 1.2 for obstetric abdomen X-rays (Table 11,
Appendix 1, Ministry of Health, 1960). In a limited survey in
1978-9 film number was 1.0 and 1.2 respectively (Wall et al.,
1980).
Table XVII Average fetal whole body dosea per examination and per
X-rayfilminpelvimetric andobstetricabdomenexaminations in 1958in
Britain (from unpublished data collected by the Adrian survey: the late
Professor R.E. Ellisb, personal communication, 1963).
Film nwnber Average whole body dose R
per Number of per per
examination examinations examination film
Pelvimetry 1 69c 1.11 1.11
2 28 0.94 0.47
3 9 1.49 0.50 0.47
4 4 1.69 0.52
Alld 1.s3e 110 1.12f
Obstetric 1 90 0.40 0.40
Abdomen 2 21 0.89 0.45
Allg 3 1 0.92 0.31
1.21 112 0.50h 0.41
aObservations by Bewley et al. (1957) and Clayton et al. (1957)
provided factorsallowingaverage fetaldoseperunitmaternal skindose
to be deduced for each projection and each X-ray quality used in the
X-rayexaminations ofthe Adrian survey. This factormultiplied by the
maternalskindosemeasuredinaparticularexamination gavethewhole
body fetal dose for that examination. Marrow dose in a fetus was taken
to be the same as its whole body dose. 'formerly Secretary, Panel of
Physicists, Adrian Committee. C63 ofthe 69 consisted solely ofa single
lateral 'view'. The tendency to use one lateral film only in examinations
termed 'pelvimetry' seemed to increase dose per film as compared with
examinations using several films. d1 1 Inlet, 21 Outlet, 102 Lateral, 22
A-P, 12 P-A. '1.53 (Ellis, personalcommunication) isnotthesameas 1.7
in theAdrian Committee Report(Table II, MinistryofHealth, 1960)for
unknown reasons. 'In hospitals with more than 300 beds and less than
300 beds average dose was 0.81 R in 73 examinations and 1.7 in 37
examinations (ranges 0.13-4.9 R and 0.17-3.5 R) respectively. Mean
number offilms per examinations was 1.3 and 1.9. '58 A-P, 51 P-A, 22
Lateral. "In hospitals with more than 300 beds and less than 300 beds
average dose was 0.47 R in 73 examinations and 0.55 R in 39
examinations (ranges 0.03-2.1 R and 0.03-2.0 R) respectively.
Six years after the Adrian Committee investigations
The Sheffield Hospital Region had been the most successful
of all in 1958, determining dose in 18% more examinations
than requested (Osborn, 1960). Six years later in 1964
population gonad dose was re-assessed using the same
methods and on a larger scale (Matthews & Miller, 1969).
Mean fetal gonad dose per pelvimetry was 710 mR, close to
the 1958 national average, and for obstetric abdomen
examinations was 203 mR, much smaller than the 1958
national average 720 mR. A reason for this substantial
decrease was not given. Film numbers per examination for
different kinds of non-obstetric X-ray examinations were
similar to the 1958 national averages.
Twenty years after: a National Radiological Protection Board
survey
During the years after 1958 radiation dose should have
decreased as a result of technical changes in diagnostic
radiology, including faster films and rare earth screens.
Measurements in a limited survey in 1978/9 (Wall et al.,
1980) showed some reduction in dose, by 50% for fetal
gonad dose in obstetric abdomen examinations. (The term
'fetal maturity' in Wall et al. (1980) is synonymous with
obstetric abdomen: Dr S. Rae, personal communication,
1989). Rare earth screens were used in 70% of the obstetric
dose determinations but for general obstetric work in only
five of 21 hospitals surveyed. Thus the measured fetal dose in
1978/9 will overestimate the nationwide dose reduction since
1958. Mean fetal gonad dose from an obstetric abdomen
X-ray was 347 cGy, larger than 203 mR, the 1964 value of
Matthews and Miller (1969).
Determination of intrauterine dose in obstetric radiography
Intrauterine (and ovary) dose cannot be measured in vivo but
only in phantoms with the physical dimensions of a pregnant
woman's abdomen. Dose can be measured on the abdominal
surface of a phantom and at the corresponding points in vivo
on the abdomen of a pregnant woman. Inferences can then
be made about the intrauterine (and ovary) dose in vivo using
scaling factors, derived from direct knowledge of the position
of measuring devices within a phantom, and assumptions
about the detailed geometry of the position of uterus and
fetus within the pregnant abdomen in vivo. The scaling fac-
tors will vary with the conditions of irradiation, such as
X-ray kilovoltage and filtration, distance of X-ray tube focus
from the abdominal surface and the X-ray film, etc. Scaling
factors were derived by Bewley et al. (1957) and Clayton et
al. (1957) and all assessments of fetal dose and of maternal
gonad dose in Adrian survey reports (Ministry of Health,
1960, 1966) were based on their work. Each investigation
dealt in detail with dose from different pelvimetric views,
seven in Clayton et al. (1957), three in Bewley et al. (1957),
and the latter also gave fetal and maternal doses for lateral
and PA obstetric abdomen examinations.
During early pregnancy the gonads of embryo or fetus
within the uterus lie near the maternal ovaries. During late
pregnancy, when most obstetric radiography is done, the
distance between them increases as the maternal ovaries are
pushed cephalad by the expanding uterus. Thus the relation-
ship of dose in maternal ovary and in fetus changes with
stage of pregnancy.
The Final Adrian Committee Report gave estimates of
mean whole-body fetal dose from pelvimetry and from ob-
stetric abdomen examinations made in 1958 (Table II, Minis-
try of Health, 1966). These referred to late pregnancy when
90-95% of all these examinations are made. Whole body
dose was taken to be an estimate of marrow (haematopoietic
tissue) dose and thus of the relevant dose for induction ofall
childhood cancer, including leukaemia.
Fetal gonad and whole body dose may be very different
(Table XVIII). Their ratio varied from 0.2 to 3.5 for threeCHILDHOOD CANCER AND PRENATAL IRRADIATION 163
Table XVIII Fetal gonad and whole body dose from obstetric X-ray examinations in late pregnancy
Meanfetal gonad Fetal Maternal
dose (R) whole body gonad dose
dose (R) mean (R)
From Bewley et al. (1957) assuming specific conditionsfor radiography
a b c a
Pelvimetry projection No. 2 Lateral 0.06, 0.14 0.1 0.3 0.1
No. 3 Outlet 0.01, 0.02 0.02 0.1 0.03
No. 4 Inlet 4.6 , 2.8 2.8 0.8 0.5
Obstetric Lateral 0.15, 0.18 0.2 0.25 1.0
Abdomen Postero-Anterior 0.12, 0.17 0.15 0.15 0.2
From Adrian Committee survey measurements nation-wide
e f e
Pelvimetryd 0.89 1.12 0.75
Obstetric abdomen 0.72 0.50 0.37
aDose for vertex presentation with fetal gonads respectively 5 or 8 cm below the surface of phantoms
(plastercastsat term ofabdomen ofone smalland onelargepregnantwoman) (Table I, Bewleyetal., 1957).
bAveragedoseallowingforrelative frequencyofvertexandbreechpresentations forinletviewwith 'effective
depth' ofgonads 7 cm: the averaging process isnecessarily extremely rough (Table I and text, Bewley etal.,
1957). cTable II, Bewley et al. (1957). dTable XVI classifies views in pelvimetry giving associated doses
measured in 1958. eTable I, Ministry ofHealth (1960). fTable II, Ministry ofHealth (1966) and Table XVII.
pelvimetric projections but only from 0.8 to 1.0 for lateral
and PA obstetric abdomen views (Bewley et al., 1957). The
ratio of the Adrian survey mean values was 0.8 for pelvi-
metry and 1.4 for obstetric abdomen (Table XVIII). The
ratio of gonad to whole body dose in the fetus for different
pelvimetric projections is directly correlated with magnitude
of fetal gonad dose. The highest ratio 3.5 corresponds to the
highest fetal gonad dose 2.8-4.6 R (for projection 4, Table
XVI) and the lowest ratio 0.2 with the lowest fetal gonad
dose 0.01-0.02 R (for projection 3, Table XVI). The mix of
projections can be different in individual pregnant women. So
'dose from pelvimetry' is an uncertain basis for estimating
risk of childhood cancer.
Differential radiosensitivity according to stage of development
in utero
In the years 1944-78, 90-95% of all X-raying in pregnancy
was in the third trimester (Table XIV), 92, 89, 95 and 95%
for birth years 1939-49, 1950-9, 1960-9 and 1970-81 (Gil-
man et al., 1989b).
As would be anticipated, X-raying involving conceptus and
embryo was mainly for non-obstetric reasons (Table XIV).
For examinations in the first 0-7 weeks post-conception
(2-9 weeks after the last menstrual period) the case/control
ratio for X-raying was 4.4 for non-obstetric X-rays. This
could reflect either an increased intrinsic sensitivity to X-rays
in early pregnancy or a higher dose in non-obstetric examina-
tions.
Stewart and Kneale (1970b) noted that 'the "extra" cancer
risk for children X-rayed within 3 months of conception was
more a dose effect than a susceptibility effect'. Over 50% of
first trimester examinations of cancer cases and controls
involved more than four films compared with 20% and 6%
respectively for second and third trimester examinations (loc.
cit.). However, soon afterwards, Stewart (1971), after writing
that first trimester exposures are more dangerous than later
exposures, continued 'an immature foetus is more vulnerable
to the tumour induction effects of radiation than a mature
foetus'. This does not follow unless the 'extra' cancer risk is
too large to be explained by the 'extra' dose associated with
the 'extra' film number per examination plus the additional
dose from fluoroscopy when contrast media are used (but not
included in the OSCC assessments of dose based on dose per
film and film number).
Dose from fluoroscopy (unlike radiography) cannot be
standardised. Dose per minute in tissue depends on emission
rate from the X-ray tube and the duration of a fluoroscopy
varies characteristically between individual radiologists
(Osborn, 1963). Normally no information is recorded at the
time of a fluoroscopy that would allow an estimate of radia-
tion dose in the subject on that particular occasion. The care
taken by the radiologist in coning the field of view and
avoiding exposure of the uterus is possibly the crucial factor
determining intrauterine dose.
First trimester examinations used four to five films per
examination (Table XIX), 2-3 times more than in third
trimester obstetric X-rays (Table XI). About one in four of
non-obstetric X-rays in early pregnancy involved fluoroscopy
(Table XIV), dose from fluoroscopy is likely to be higher
than for any number offilms, and OSCC assessments of dose
have not included any dose from this source. Non-obstetric
X-ray examinations were more frequent in future cancer
cases than controls, 10.5% and 1.9%, only in the earliest
years 1939-49, when doses were presumably relatively high.
In 1950-81 frequencies were similar, 4.9 and 4.1% (records
of reason for X-ray in Table 4, Gilman et al., 1989b). These
factors taken together show that fetal dose in OSCC was
markedly higher for non-obstetric than obstetric X-rays, i.e.
markedly higher for X-raying in early pregnancy than in late
pregnancy.
Data for X-raying at different times within the first
trimester, when nearly all X-rays were for non-obstetric pur-
Table XIX Number of future cancer cases/future controls with
dated X-rays in early pregnancy (Oxford Survey of Childhood
Cancer data)
Month ofpregnancy First trimester
Films per
Birth years Death years First Second Third Total examination
anot stated b1953-67 11/0 11/0 16/4 38/4 4.78
C1944-78 1953-79 15/4 14/4 22/7 51115d 4.63
'by difference' 4/4 3/4 6/3 13/11
aIn the first trimester zero rate of dated X-rayings is reported for
the controls of birth years 1939-49 and 8, 4 and 2 controls were
X-rayed in 1950-9, 1960-9 and 1970-81 respectively (Table 3,
Gilman et al., 1989b), suggesting that birth years for the first row of
Table XIX did not extend past 1959. bfrom Table XII in Bithell &
Stewart (1975). 'from text and Table 5 in Gilman et al. (1988)
assuming that weeks 0-5, 6-9 and 10-13 correspond with the first,
second and third month of pregnancy in Table XII in Bithell &
Stewart (1975) and excluding the 4 cancer cases in the top row and 1
control in the second row of Table 5 in Gilman et al. (1988), cf.
footnotes b,c in Table XIV. The total number of controls with dated
X-rays in the first trimester is then 15. dTable 3 (Gilman et al.,
1989b) stated that 1.2% of 1133 = 14 controls were X-rayed in the
first trimester. The rate should have been 1.32% of 1133 = 15
controls (Knox et al., 1989, personal communication).164 R.H. MOLE
poses, are given in Table XIV. Risk (case/control ratio) was
not higher in the first few weeks of intrauterine development.
Reports in 1975 and 1988 (footnotes b and c, Table XIX)
gave different case/control ratios for X-raying in the first
trimester, 9.5 and 3.4, but the same film number per
examination. The 1988 data are the 1975 data plus additional
information. The case/control X-raying ratio for the addi-
tional information was 1.2 (cf. row labelled 'by difference',
Table XIX), smaller than for birth years before 1958 (Tables
VIII, IX and X), and showing that the high ratio of 9.5 was
confined to early birth years. These were not given in the
1975 report but cannot have been later than 1959 (footnote
a, Table XIX): most were probably earlier.
The data for X-raying in the first trimester are consistent
with a substantial change in requests for radiology in the late
1950s or late 1940s. After 1949 X-rays for non-obstetric
reasons were no longer 5 times more frequent in future cases
than future controls (Gilman et al., 1989b). Alternatively
some of the difference between the 1975 and 1988 reports
may be related in some way to the high proportion of
pre-1960 deaths with incomplete X-ray records (Kneale &
Stewart, 1976b).
Some women had several X-ray investigations during the
same pregnancy. The data relating to the first X-raying were
used when analysing the dose response and the timing of
X-ray (Bithell & Stewart, 1975). This procedure assumes that
the earlier stages of pregnancy in utero are the most sensitive
to cancer induction, for which, as has been seen, there is no
dependable evidence. A valid comparison (not yet made)
would be between subjects having only a single X-ray
examination in pregnancy, some early and some late.
The concept underlying the so-called ten day rule, the need
to minimise X-raying in the first two post-conception weeks,
was introduced by the International Commission on
Radiological Protection in 1959 in the context of occupa-
tional exposure. The 'rule' was formalised for medical radiog-
raphy in Britain by a DHSS recommendation in 1972 (now
superseded). It was not based on fear of cancer but on a
mistaken belief that the human conceptus is sensitive to
induction of malformations by irradiation (Mole, 1987a).
Emphasising a supposed sensitivity to radiation car-
cinogenesis at the earliest stages of human development in
utero has distracted attention from the fact that 95% of
obstetric X-rays are in the third trimester. Reducing X-raying
in the third trimester would reduce radiation-induced child-
hood cancer. If third trimester diagnostic X-rays have con-
tributed to the progressively decreasing perinatal mortality
over recent decades, the desirable degree of reduction in
X-raying depends on balancing risk and benefit to children
yet to be born.
The embryo is the stage of development during which
organ primordia are laid down. Most childhood cancer
(apart from leukaemia) can be classified by organ of origin.
Do all classifiable cancers originate after the corresponding
organ primordium has formed? A characteristic burst of cell
division occurs in all mammalian embryos soon after the
primitive streak becomes evident, in humans in the third
week post-conception. Any cell in an early embryo already
transformed by carcinogenic action would participate in this
outburst of division, leading to death within a few days and
loss of pregnancy rather than from cancer diagnosed in
childhood. Judged by cancer deaths in childhood, radiog-
raphy in the first few weeks post-conception should be less,
rather than more, risky than in later pregnancy.
Radiation dose per X-ray film an inadequate basis for risk
estimation
All older and newer assessments of risk factors for car-
cinogenesis by fetal irradiation use, as a surrogate for fetal
tissue dose, the product of film number per X-ray examina-
tion and a common value ofdose per X-ray film for obstetric
X-ray examinations of all kinds at a given date. This ap-
proach seems no longer justifiable.
The earliest risk assessment, by Stewart and Kneale
(1970a), used dose estimates per film decreasing
systematically from 460 to 200 mrad over the years 1943-65
but the basis for these values and for the change over time
has never been published. Gonad and whole body dose were
not distinguished. In 1958 fetal gonad dose per film was 600
and 520 mR for obstetric abdomen and pelvimetry respec-
tively (Table I and Appendix Table 11, Ministry of Health,
1960). These values are double the 250 mR per film for 'mean
fetal dose' in 1955-59 used by Stewart and Kneale (1970a).
That lower value had been provided by Dr G.M. Ardran
after consideration of radiological practice and the literature.
'The accuracy of the Ardran estimates is an unknown
quantity' (Stewart & Kneale, 1973).
Values for fetal dose in obstetric radiography in Britain
over the 23 years 1943-65 were given by UNSCEAR (1972),
mean dose per film decreasing from 1,800 to 200 mrad. All
UNSCEAR values were said to be derived from the British
literature, the latest citation dated 1957 but dose given up to
1965. All cited references were to studies in teaching hos-
pitals: doses there cannot be accepted as average values for
all Britain. Adrian Committee Reports (1960, 1966) were not
listed. These unjustified UNSCEAR values, and the mistaken
assumption that cancer risk is directly dependent on film
number per X-ray examination, were the basis for risk fac-
tors derived by UNSCEAR (1972) and 16-17 years later by
Bithell and Stiller (1988) and Muirhead and Kneale (1989).
Table XVII gives unpublished information from the
Adrian survey on fetal whole body dose per X-ray film. Dose
per film is far from constant. When the Adrian survey
measurements were made in 1958 the fetal dose per film for
pelvimetry using a single film was more than twice as high as
for pelvimetry using multiple films. It was more nearly
independent of number of films in obstetric abdomen
examinations (Table XVII).
Primary data on film number per X-ray were always less
adequate than for other OSCC observations. Some numbers
were recorded, some were estimates many years in retrospect
about how many films were thought to have been used.
Information was missing for an unstated proportion of sub-
jects. A larger mean film number for X-rayed cancer cases
than for X-rayed controls was found only in early birth years
of the OSCC (Figure 2; Gilman et al., 1989b). Updated
OSCC analysis no longer shows any association between
cancer risk and number of films per X-ray obtained from
medical records (Table XII; Gilman et al., 1988).
It is wrong in principle to expect a common value of fetal
dose per X-ray film, independent of the purpose of an obste-
tric X-ray examination and of the geometric relationships of
X-ray tube focus, X-ray beam, the body of the fetus, the
maternal abdomen and the X-ray film. The range of mean
fetal gonad dose for differing projections in pelvimetry was
16-fold (Table XVI). Dose reduction by ceasing to use
Thoms' view, when fetal dose in routine pelvimetry exceeds
2,000 mR for a single film, was considerably greater than by
reducing number of X-ray films per pelvimetry by one. In
Britain Thom's view had been virtually abandoned by 1958,
the year when mean fetal gonad dose in pelvimetry was
885 mR, when only 15 of 110 determinations exceeded
2,000 mR (Figure SF, Appendix I, Ministry of Health, 1960)
and only 10 of the 15 were Thoms' inlet view (Table XVII,
footnote d).
Modern statistical developments may allow the quan-
titative importance of individual carcinogenic factors to be
distinguished by stratified analyses and were applied in recent
derivations of risk factors for obstetric radiography (Bithell
& Stiller, 1988; Muirhead & Kneale, 1989). But analyses
based on the assumption that dose per film is a constant at a
given date and that its product with number of films per
examination is an adequate surrogate for fetal tissue dose
cannot be trustworthy, however sophisticated the analyses
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Evidence that prenatal X-ray exposure is a cause of childhood
cancer
In the 1950s and 1960s the dogma that genetic damage
depended linearly on gonad dose and without a dose
threshold was never criticised. But until fairly recently the
application of the corresponding hypothesis to cancer induc-
tion by radiation was strongly resisted. Indeed Stewart and
Kneale's initial finding (1970a) of a quantitative relationship
between rate of excess cancer and number of films per X-ray
examination in OSCC data seemed at the time to be the first
direct evidence in man that linearity without threshold for
radiation carcinogenesis might have some plausibility.
Observations on twins
A cogent and independent line of evidence, based on OSCC
observations but independent of film number and radiation
dose, shows that prenatal exposure to diagnostic X-ray
examinations can cause childhood cancer. Excess rates of
childhood leukaemia and cancer in the X-rayed were vir-
tually the same in singleton births and in twins although
10% of singletons and 50-60% of twins were irradiated
(Mole, 1974). Independently of the gross difference in pro-
portion of subjects X-rayed, the same number of excess
cancers was found when the same number of fetuses, sing-
letons or twins, were exposed (presumably) to the same dose.
This is as predicted if X-raying is causal but not if mothers
selected for X-raying were already destined to have children
with an above average cancer rate.
Past findings in twins cannot be compared with updated
OSCC information limited to singleton births (Knox et al.,
1987; Gilman et al., 1988). Data for twins set out as for
singletons in Tables I-VII would be useful. In NBT data
50-60% of twins were X-rayed in utero in 1958 (Stewart,
1973) and even more, 73%, in 1970 (Dr J. Golding, personal
communication, 1989).
Confirmatory evidence from USA showed an excess of
childhood cancer in irradiated twins (relative risk (RR) 2.4
with 95% CI 1.0-5.9, Harvey et al., 1985). The correspond-
ing data on singleton births in an extended USA survey of
childhood cancer and X-raying in pregnancy showed a
significant association between leukaemia frequency and
intrauterine X-ray exposure (RR 1.52 with 95% CI
1.18-1.95) but not for solid tumours (RR 1.3, lower 95% CI
0.95). (Monson & MacMahon, 1984; MacMahon, 1985). The
excess risk (RR- 1.0) is much higher in twins than single-
tons, as predicted by the causal hypothesis, but the CI of
each RR are much too wide for definite conclusions: the
population sample in USA was much smaller than in Britain.
A factor affecting comparisons is that in Britain rates for
leukaemia and solid cancers in the unirradiated were each
smaller in twins than in singletons (Mole, 1974).
MacMahon was reluctant to accept that prenatal X-raying
did cause cancer. Being (or being suspected of being) 'a twin
no doubt accounts for the substantially higher frequency of
X-ray exposures in twin pregnancies. But the fact of a twin
pregnancy did not exclude all other indications for radio-
graphy; one of these may have been the mysterious third
factor, and it could operate in both single and twin pregnan-
cies' (MacMahon, 1985). This is saying merely that causation
by X-rays need not be the only factor in an association of
prenatal X-rays and extra childhood cancer. This cannot be
denied: it is clear that proof of causation cannot of itself
disprove the existence of some other factor and vice versa
(Mole, 1974). Doll (1981) and MacMahon himself (1985)
stressed that this theoretical 'third' factor remained elusive in
spite of intensive attempts to unearth it.
Correlated change in excess cancer and X-raying rate
A reduction in fetal radiation dose from obstetric radio-
graphy, beginning suddenly in 1957/8, was associated with a
corresponding and significant reduction in odds ratio for
childhood cancer mortality in children born during the next
8-12 years (Table XIII). The motive for decreasing fetal
radiation dose was primarily to reduce population gonad
dose and, therefore, to reduce hereditary damage. A reduc-
tion in childhood cancer associated with reduction in dose
from medical radiology in the face of disbelief that low doses
of radiation could cause cancer may be in some sense a
serendipitous event but that only reinforces the strong
inference that fetal irradiation by medical radiography is
truly carcinogenic.
Ifdiagnostic radiography does cause cancer, the increase in
rate ofX-raying ofearly 1970 births (Figure 1) would tend to
increase childhood cancer. Cancer deaths at 0-5 years old
did increase in 1970-6 births as compared with 1958-69
births (Table VIII) but not significantly. Most OSCC cancer
data for birth years 1970 onwards are not yet published
(Tables VIII, IX and X). Conclusive evidence that diagnostic
X-rays do cause cancer would be a marked decrease in
childhood cancer in those born most recently and whose
antenatal care involved ultrasound rather than X-rays.
Carcinogenic risk of irradiation in utero
When observations are collected over several decades pooling
the data may conceal discontinuous step-like changes. Such
changes occurred before 1950 in the case-control ratio of
film number per examination (Figure 2) and in requests for
radiology in pregnant women for non-obstetric reasons, and
in the late 1950s in mean number offilms per X-ray examina-
tion (Table XI; Adrian survey) and in the case-control ratio
of X-raying rate (Figure 1). In the late 1950s the abrupt
changes were the result of pressure to reduce fetal gonad
dose for fear of genetic hazards. I was wrong to infer (Mole,
1989) that the dating of the change indicated a response to
the first OSCC publications showing an association between
excess childhood cancer and diagnostic X-raying in preg-
nancy.
When substantial changes occur in diagnostic radiography
in a discontinuous manner and radiation dose is to be cor-
related with cancer mortality (or incidence), it is essential to
derive the data to be compared from the same calendar
period. In fact the only nationwide measurements of dose in
obstetric radiography in Britain with which to compare
OSCC cancer data are those made in 1958 in the course of
the Adrian survey. The relevant dose is mean dose in the
fetal body. This, not gonad dose, is the basis for car-
cinogenesis by prenatal irradiation.
A risk co-efficientfor carcinogenesis by diagnostic radiography
ofthefetus
The OSCC category 'all malignant tumours' included CNS
tumours (Bithell & Stewart, 1975). National data on deaths
from malignant neoplasms for 1952-60 births (Draper et al.,
1982) excluded all other CNS, intracranial and intraspinal
tumours because these are sometimes without histological
confirmation. The Childhood Cancer Research Group,
University of Oxford, has kindly provided data for birth
years 1958-72. Deaths from malignant neoplasms alone and
combined with deaths from all other tumours at ages 0-14
years are given in Table XX with corresponding population
rates.
Death rates at ages 0-14 for birth years 1958, 1959 and
1960 were the same (Table XX). In 1961 the childhood
cancer death rate decreased by 8-9% and continued to
decrease progressively during the next decade, presumably as
a result of improved therapy. Mean death rate at ages 0-14
for the three birth years 1958, 1959 and 1960 was 112.8 per
100,000 for malignant neoplasms plus all other CNS, etc.,
tumours. When increased by 15/14 this gives a lethal tumour
rate at ages 0-15 years = 12.1 per 10,000 per year.
OR after X-raying in utero in Britain in the four birth
years 1958-61 was 1.27, 1.36 and 1.02 for cancer deaths at
ages 0-5, 6-9 and 10-15 respectively (Tables VIII, IX and
X). OR= 1.23 for all ages 0-15 years, with 95% CI
1.04-1.48. Thus the excess lethal tumour rate from X-raying166 R.H. MOLE
Table XX Cancer death rates in Great Britain by year of birth 1958-72 at ages 0-14 years (data
from C.A. Stiller, personal communication, 1989)
Number ofdeaths aged 0-14 Rateper 10,000
Malignant plus
Malignant all other CNS
Malignant plus neoplasms neoplasms'
Birth Number of Malignant all other CNS per 4-year per 4-year
year births neoplasms neoplasmsa year average year average
1958 840,196 921 977 10.96b 11.63
1959 847,752 856 929 10.10b 10.96
1960 886,297 948 998 10.70b 10.32 11.26 11.02
1961 912,450 868 934 9.51 10.24
1962 943,070 879 937 9.32 9.94
1963 956,746 903 972 9-44 10.16
1964 980,327 890 947 9.08 r 9.86
1965 963,385 842 910 8.74 9.45
1966 946,359 836 899 8.83 9.50
1967 928,385 843 907 9.08 9.77
1968 914,058 739 794 8.08 8.69
1969 887,828 710 763 8.00 J 8.59
1970 871,821 689 756 7.90 8.67
1971 869,883 674 725 7.75 (7.72) 8.33 (8.28)
1972 803,990 604 625 7.51 7.77
aincludes additonally all deaths from benign and unspecified CNS/intracranial/intraspinal tumours. For
tumours in these sites without histology the distinction between malignant and non-malignant is somewhat
arbitrary. 'The mean ofthetabulated values for 1958-60 is 10.6. The rates in Draperetal. (1982) are 10.83,
10.05 and 10.55 (mean 10.5) respectively. The small differences between the published rates and those
tabulated here originate in reclassification of some neoplasms.
in utero was 0.23 x 12.1 x 10-4= 2.8 x 10-4 with 95% CI
0.48-5.8 x 10-4, using the 3-year mean national death rate
as the base line.
Mean fetal whole body dose in 1958 was 0.5 rad for
obstetric abdomen and 1.12 rad for pelvimetry (Table
XVIII). There were 0.8 examinations per 1,000 persons for
the former, 0.19 for the latter (Table AII, Ministry of Health,
1966), giving a weighted mean 0.61 rad for whole body dose
in irradiated fetuses from all obstetric radiography. This
value for fetal dose can be taken to apply over the four birth
years 1958-61, given that changes from 1958 to 1964 and
subsequently were small, as discussed earlier. An excess
cancer death rate 2.8 x 10-4 caused by 0.61 cGy gives a risk
coefficient 4.6 x 10-4 per cGy with 95% CI 0.8-9.5 x 10-4
per cGy. It applies directly to X-raying in the third trimester
(cf. Table XIV) and to deaths at ages 0-15.
This seems to be the only value for risk ofcancer mortality
after irradiation in utero based on independent determina-
tions of dose and of risk in nationwide samples of the same
population of subjects. It is not based on extrapolation or an
unreliable dose-response. It applies equally to cancer
incidence and cancer mortality at ages 0-15 years because
incidence and mortality were the same.
The mean cancer rate for the four birth years
1958-61 = 11.02 deaths per 100,000 (Table XX). The risk
co-efficient derived as before has the value 4.5 x 10-4 per
cGy, virtually equal that derived above using a three birth
year mean. Whether the slight reduction in lethal tumour rate
for the birth year 1961 as compared with 1958-60 is at-
tributable to therapy, or is a chance finding, it has virtually
no influence on the value of a risk co-efficient for induction
of lethal tumours by radiography in utero.
Japanese bomb survivors irradiated in utero
Two cancers (neither leukaemia) occurred at ages 0- 15
years: one subject died with liver cancer and one continued
to survive having had Wilm's tumour. The apparently low
rate of childhood cancer after exposure to bomb radiation
has often been regarded as conflicting with the higher rate
found after prenatal medical radiology. Statistical and radio-
biological considerations show that such an inference would
be a mistake (Mole, 1974; UNSCEAR, 1977). It continues to
be made (e.g. in UNSCEAR, 1988).
The upper limit of the two-tailed 95% CI for risk based on
the two cancer cases observed at ages 0- 14 years is
2.79 x 10-4 per population-cGy DS86 dose (Yoshimoto et
al., 1988) and for one cancer death is 2.2 x 10-4 per cGy (the
95% upper CI for two and one are 7.2 and 5.6 respectively).
Both values are well within the 95% CI (0.9-9.5 x 10-4 per
cGy) for the risk coefficient derived here for diagnostic X-
rays and applicable to both cancer mortality and incidence at
0-15 years of age.
Much of the total population dose in bomb survivors
irradiated in utero came from the highest dose group
(Yoshimoto et al., 1988). Its exposure was at levels that make
obligatory an allowance for inactivation of transformed cells
by the same dose that was responsible for the transformation
(Mole 1974, 1984). If standard radiosensitivity of cells is
assumed (b in eh-D = 0.01 cGy-'), the risk coefficients for
both childhood cancer mortality and incidence in bomb sur-
vivors irradiated in utero would be larger by 2 times (or
more) (judging by the distribution of T65D doses, Mole,
1974). This would make the apparent difference between
bomb radiation and medical radiology even smaller. If fetal
cells are thought to be more sensitive to inactivation by
radiation than cells in the adult, the corrected value for risk
in bomb survivors would be further increased.
No case of childhood leukaemia was seen in bomb sur-
vivors exposed in utero. The 95% upper Poisson limit for
zero is 3.7, 2/3 of the value 5.6 for one case, and the excess
of leukaemia after prenatal X-raying is about half that for all
childhood cancers (Bithell & Stewart, 1975). The same
arguments as for all cancers show that an absence of child-
hood leukaemia in bomb survivors exposed in utero is also
not a genuine discrepancy.
I am very indebted to those who initiated and maintained the Oxford
Survey of Childhood Cancer, to Dr Alice Stewart in the first place,
and to Professor George Knox, Dr George Kneale, and Miss Estelle
Gilman, her current colleagues. The unpublished information they
have given me is referred to in the text and tables as a personal
communication from Knox et al. (1989). They are not responsible in
any way for the use I have made of the data. I consulted many
people, those who provided unpublished information cited as per-
sonal communications and others too many to thank by name. Dr
Sidney Osborn's thesis (1960) was an essential source of contem-
porary information. Mr David Papworth, Medical Research Council
Radiobiology Unit, Chilton, gave me statistical help. Dr G.J.
Draper, Director, and Dr C.A. Stiller, Childhood Cancer Research
Group, University of Oxford, kindly provided unpublished tables of
national records of deaths from childhood cancer by year during
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